CytoDyn Announces Phase IIB Clinical Trial Agreement with Dr. Jeffrey Jacobson, Drexel University College of Medicine Nov 16, 2012 1:41pm EST
CytoDyn to Present Findings on its Feline Immunodeficiency Virus (FIV) Therapeutic Antibody Program Oct 05, 2012 8:45am EDT
CytoDyn Retains Gibraltar Associates for Corporate and Investor Communications Oct 03, 2012 10:02am EDT
CytoDyn Inc. Names Dr. Nader Pourhassan New CEO; Announces New Chief Scientific Officer Sep 11, 2012 5:52pm EDT
CytoDyn Announces Entry into Agreement with Progenics Pharmaceuticals, Inc. to Acquire PRO 140 Jul 30, 2012 2:01pm EDT
